Other inhibitors: Previous studies revealed that inhibition of VEGFC with specific siRNAs reduced the lymphangiogenesis in a murine mammary tumor model.315,316 Additionally, treatment with VEGFC siRNA effectively reduced lymphangiogenesis and significantly increased the survival rate of tumor-bearing mice. This evidence concerns the gene VEGFC and neoplasm.